Completion report on merger, etc. (asset transfer)

What happened

Completion Report on Merger, Etc. (Asset Transfer) 6.0 Vuno Co., Ltd. To the Governor of the Financial Supervisory Service September 4, 2026

Company name: Vuno Co., Ltd. Representative Executive Officer: Lee Ye-ha Head office address: 479 Gangnam-daero, 9th floor, Seocho-gu, Seoul (Banpo-dong) (Phone) 02-518-6629 (Website) http://www.vuno.co Preparer in charge: (Title) Head of Management Support Division (Name) Park Jae-hyung (Phone) 02-518-6629

I. Schedule This completion report relates to the material event report (decision on material asset transfer (other)) filed on September 10, 2025. Vuno Co., Ltd. (transferor) and My Herb Co., Ltd. (transferee) report that the transfer of assets relating to VUNO Med-BoneAge was completed on September 4, 2026, and that this transaction has accordingly concluded normally.

1. Asset transfer details and amount Counterparty (transferee): My Herb Co., Ltd. Assets transferred: VUNO Med-BoneAge Transfer amount (KRW): 2,700,000,000

2. Key schedule External valuation period: September 4, 2025 - September 10, 2025 (Daeju Accounting Corporation, external valuation institution) Board resolution date: September 10, 2025 Material event report filing date: September 10, 2025 Contract execution date: September 10, 2025 Payment date: September 10, 2025 (down payment); September 4, 2026 (balance) Transaction closing date: September 4, 2026 (balance payment date)

(*) In connection with the "Asset Transfer and Patent Transfer Agreement, Etc." executed on September 10, 2025, the transfer of the assets was delayed beyond the originally scheduled closing date due to continued discussions on related procedures during the transfer process. The parties accordingly executed an agreement on these matters dated September 4, 2026, and, as of the reporting date of September 4, 2026, the full transaction consideration, including the balance, has been paid, and this transaction is accordingly reported as concluded.

II. Changes in Ownership of Major Shareholders, Etc. -- Not applicable III. Exercise of Appraisal Rights -- Not applicable IV. Matters Relating to Creditor Protection -- Not applicable V. Status of Related Litigation -- Not applicable VI. Matters Relating to New Share Allotment, Etc. -- Not applicable

VII. Summary Financial Information Before and After the Merger, Etc. (Unit: KRW) Category: Before asset transfer / Change / After asset transfer [Current assets]: 27,908,114,672 / 2,700,000,000 / 30,608,114,672 [Non-current assets]: 21,485,645,528 / - / 21,485,645,528 Total assets: 49,393,760,200 / 2,700,000,000 / 52,093,760,200 [Current liabilities]: 12,946,672,983 / - / 12,946,672,983 [Non-current liabilities]: 2,149,889,645 / - / 2,149,889,645 Total liabilities: 15,096,562,628 / - / 15,096,562,628 [Capital stock]: 1,400,182,300 / - / 1,400,182,300 [Capital surplus]: 89,506,967,592 / - / 89,506,967,592 [Capital adjustment]: 34,176,582,070 / - / 34,176,582,070 [Accumulated deficit]: (90,786,534,390) / 2,700,000,000 / (88,086,534,390) Total equity: 34,297,197,572 / 2,700,000,000 / 36,997,197,572

(Note 1) The "before asset transfer" summary financial information above is based on the separate (non-consolidated) financial statements as of the end of the third quarter of 2025 (contract execution date: September 10, 2025). (Note 2) The "after asset transfer" financial information above reflects only a simple addition/subtraction of the amount related to this asset transfer, so actual figures may differ depending on the results of the external auditor's audit or review.